Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease

2002 ◽  
Vol 23 (0) ◽  
pp. s89-s90 ◽  
Author(s):  
L. Morgante ◽  
A. Epifanio ◽  
E. Spina ◽  
A.E. Di Rosa ◽  
M. Zappia ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Preliminary Report ◽  
Dopaminergic Psychosis

Voice target time in Parkinson's disease: A preliminary report*

1997 ◽  
Vol 117 (2) ◽  
pp. P120-P120
Author(s):  
J JIANG ◽  
E LIN ◽  
B SHEYNIN ◽  
D HANSON
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Preliminary Report ◽  
Target Time

Depression and Parkinson's Disease: Biological Therapies

2017 ◽  
Vol 41 (S1) ◽  
pp. S770-S770
Author(s):  
B. Mures ◽  
N.G. Lluis ◽  
A.P. Iñigo ◽  
M.H. German ◽  
T.G. Miriam ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Psychiatric Morbidity ◽  
Beneficial Effects ◽  
The Core ◽  
Previous Diagnosis ◽  
Medication Side ◽  
Dopaminergic Psychosis ◽  
Competing Interest ◽  
Motor Improvement

Introduction.Depression occurs in approximately 40% of patients with Parkinson's disease. Parkinson's disease is commonly associated with psychiatric morbidity, which includes depression, anxiety, and dopaminergic psychosis. These compound the patient's predicament. Fortunately, a variety of effective treatments are available.Objective.The purpose of this e-poster is to provide an update of the research regarding depression in Parkinson's disease.Methods.Describe a case report. A 56-year-old man, with previous diagnosis of Parkinson's disease. We used SSRIs, but they was not enough to successful treatment so we decided to use ECT.Results.Our patient failed to respond to medication or develop intolerable medication side effects. Electroconvulsive therapy (ECT) should be considered for this group of patients. Contrary to popular belief, ECT is a widely used and safe treatment for depression when medication fails. ECT has been shown to be effective and safe in PD for treating both depression and dopaminergic psychosis. Several studies also report varying periods of motor improvement following ECT in PD. A study is currently underway at UBC to examine this phenomenon in a controlled setting. ECT improves depression, may permit a reduction in antidepressant medications, and has intrinsic antiparkinsonian properties.Conclusions.ECT, has repeatedly been shown to have beneficial effects in PD, but has never gained acceptance as a clinical treatment option. We review the literature on the use of ECT in PD, pointing out that ECT has beneficial effects on both the core motor symptoms of PD as well as the commonly occurring psychiatric comorbidities.Disclosure of interestThe authors have not supplied their declaration of competing interest.

scholarly journals CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson’s Disease—A Preliminary Report

PLoS ONE ◽  
2016 ◽  
Vol 11 (10) ◽  
pp. e0164762 ◽  
Author(s):  
Rui Gao ◽  
Guangjian Zhang ◽  
Xueqi Chen ◽  
Aimin Yang ◽  
Gwenn Smith ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Preliminary Report ◽  
Csf Biomarkers

The impact of subthalamic deep brain stimulation on polysomnographic sleep pattern in patients with Parkinson's disease – Preliminary report

2018 ◽  
Vol 52 (4) ◽  
pp. 514-518 ◽  
Author(s):  
Jarosław Dulski ◽  
Michał Schinwelski ◽  
Agnieszka Konkel ◽  
Karol Grabowski ◽  
Witold Libionka ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Deep Brain Stimulation ◽  
Brain Stimulation ◽  
Preliminary Report ◽  
Sleep Pattern ◽  
The Impact ◽  
Deep Brain
Sign in / Sign up

Export Citation Format

Share Document